Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Abstract

No-reflow is of prognostic value in ST-segment elevation myocardial infarction (STEMI) but has not been extensively investigated in young patients. Young patients with STEMI admitted within 12 hours from symptom onset and treated by primary percutaneous coronary intervention (pPCI) were recruited. Patients were classified into 2 groups based on postintervention thrombolysis in myocardial infarction (TIMI) flow grade; no-reflow: TIMI flow grade 0, 1 or 2 (group 1; n = 27; 21 men, mean age: 42 ± 4 years); and angiographic success: TIMI flow grade 3 (group 2; n = 118; 110 men, mean age: 43 ± 4 years). Adjusted odds ratios were 13.79 for female gender (P < .001; confidence interval [CI] = 1.88-101.26), 2.09 for pain to balloon time (P < .017; CI = 1.14-3.812), 12.29 for high TIMI thrombus grade (P = .012; CI = 1.74-86.94), 0.04 for tirofiban use (P < .001; CI = 0.01-0.22), 5.19 for mean platelet volume (MPV; P < .001; CI = 2.44-11.01), and 1.008 for platelet–lymphocyte ratio (PLR; P = .034; CI = 1.001-1.016). In conclusion, female gender, pain to balloon time, high TIMI thrombus grade, tirofiban, MPV, and PLR were independent predictors of no-reflow in young patients with STEMI after pPCI.

Keywords

ST-segment elevation myocardial infarction primary percutaneous coronary intervention young patients pain to balloon time thrombus grade female gender

Get full access to this article

View all access options for this article.

References

Choudhury

Marsh

. Myocardial infarction in young patients. Am J Med. 1999;107(3):254–261.

Esteban

Montero

Sánchez

JJA

. Acute coronary syndrome in the young: clinical characteristics, risk factors and prognosis. Open Cardiovasc Med J. 2014;8:61–67.

Cengel

Tanindi

. Myocardial infarction in the young. J Postgrad Med. 2009;55(4):305–313.

Durante

Camici

. Novel insights into an “old” phenomenon: the no reflow. Int J Cardiol. 2015;187:273–280.

Celik

Kaya

Akpek

. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology. 2015;66(2):155–162.

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985;312(14):932–936.

Schwartz

Kloner

. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873–882.

Young

Cox

Stuckey

. Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registry. J Interv Cardiol. 2007;20(1):44–50.

Mehta

Harjai

Boura

. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2003;92(12):1445–1447.

10.

Gupta

Wang

Spertus

. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64(4):337–345.

11.

Thygesen

Alpert

Jaffe

. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–2035.

12.

Colaco

Reay

Beckett

Aitchison

Mcfarlane

. False positive ECG reports of anterior myocardial infarction in women. J Electrocardiol. 2000;33 suppl:239–244.

13.

Rezkalla

Kloner

. No-reflow phenomenon. Circulation. 2002;105(5):656–662.

14.

Rezkalla

Dharmashankar

Abdalrahman

Kloner

. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010;23(5):429–436.

15.

Ito

. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3(9):499–506.

16.

Gibson

de Lemos

Murphy

. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21):2550–2554.

17.

Miranda-Guardiola

Rossi

Serra

. Angiographic quantification of thrombus in ST-elevation acute myocardial infarction presenting with an occluded infarct-related artery and its relationship with results of percutaneous intervention. J Interv Cardiol. 2009;22(3):207–215.

18.

Sianos

Papafaklis

Serruys

. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22(10 suppl B):6B–14B.

19.

Balta

Cakar

Demirkol

Kurt

Unlu

Kucuk

. The relationship between ankle-brachial index and estimated glomerular filtration rate in type 2 diabetes. Angiology. 2013;64(3):242.

20.

Lang

Bierig

Devereux

. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108.

21.

Zimmerman

Cameron

Fisher

Grace

. Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry). J Am Coll Cardiol. 1995;26(3):654–661.

22.

Rathod

Jones

Gallagher

. Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction [published online January 14, 2015]. Eur Heart J. 2015.

23.

Hosseini

Soleimani

Karimi

. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi Arch Chest Dis. 2009;72(2):71–76.

24.

Dong-Bao

Zhi

Shan

Wei-ying

. Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction. Clin Res Cardiol. 2009;98(12):773–779.

25.

Kurtul

Murat

Yarlioglues

Duran

Celik

Kilic

. Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. Angiology. 2015;66(7):644–651.

26.

Ndrepepa

Tiroch

Fusaro

. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55(21):2383–2389.

27.

Balta

Celik

Mikhailidis

. The relation between atherosclerosis and the neutrophil-lymphocyte ratio [published online Febuary 9, 2015]. Clin Appl Thromb Hemost. 2015.

28.

Martin

Plumb

Kilbey

Kishk

. Changes in volume and density of platelets in myocardial infarction. Br Med J (Clin Res Ed). 1983;287(6390):456–459.

29.

Balta

Demirkol

Celik

Akgul

. Mean platelet volume as a surrogate marker of long-term mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2013;112(1):142.

30.

Kurtul

Yarlioglues

Murat

. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(3):342–347.

31.

Peterson

Syndergaard

Bowler

Doxey

. A systematic review of factors predicting door to balloon time in ST-segment elevation myocardial infarction treated with percutaneous intervention. Int J Cardiol. 2012;157(1):8–23.

32.

Goto

Lansky

Nikolsky

. Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. JACC Cardiovasc Interv. 2011;4(7):769–777.

33.

Dong-Bao

Zhi

Shan

Wei-Ying

. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol. 2010;33(12):E7–E12.

34.

Carrabba

Santoro

Balzi

. In-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry). Am J Cardiol. 2004;94(9):1118–1123.

35.

Dreyer

Ranasinghe

Wang

. Sex differences in the rate, timing and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation. 2015;132(3):158–166.

36.

D’Onofrio

Safdar

Lichtman

. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131(15):1324–1332.

37.

Simon

Mary-Krause

Cambou

J-P

. Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nation-wide USIC registries. Eur Heart J. 2006;27(11):1282–1288.